Peter Jeffrey Conn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter jeffrey conn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Jeffrey Conn Today - Breaking & Trending Today

Karuna Therapeutics' (KRTX) Neutral Rating Reiterated at Cantor Fitzgerald

Karuna Therapeutics' (KRTX) Neutral Rating Reiterated at Cantor Fitzgerald
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Troya Ignelzi , Peter Jeffrey Conn , Andrew Miller , Lauriej Olson , Eric Elenko , Ballentine Partners , Financial Services Group Inc , Karuna Therapeutics Company Profile , Fiera Capital Corp , Calamos Advisors , Royal Bank , China Universal Asset Management Co , Jpmorgan Chase Co , Morgan Stanley , Karuna Therapeutics Inc , Cantor Fitzgerald , Karuna Therapeutics , Free Report , Moderate Buy , Get Free Report , Director Laurie , Services Group , Universal Asset Management , Capital Corp , Karuna Therapeutics Daily ,

Karuna Therapeutics (NASDAQ:KRTX) Now Covered by Wells Fargo & Company

Wells Fargo & Company initiated coverage on shares of Karuna Therapeutics (NASDAQ:KRTX – Free Report) in a research report sent to investors on Tuesday, Marketbeat reports. The brokerage issued an overweight rating and a $225.00 price target on the stock. A number of other research analysts have also recently commented on the stock. JPMorgan Chase […] ....

United States , Jeffreym Jonas , Andrew Miller , Peter Jeffrey Conn , Eric Elenko , Troya Ignelzi , Karuna Therapeutics Inc , Royal Bank , Advisors Inc , Financial Services Group Inc , Jpmorgan Chase Co , Morgan Stanley , Wells Fargo Company , First Horizon Advisors Inc , Wells Fargo , Karuna Therapeutics , Free Report , Moderate Buy , Get Free Report , Director Jeffrey , Horizon Advisors , Services Group , Parallel Advisors , Karuna Therapeutics Daily , Nasdaq Krtx , Initiated Coverage ,

Karuna Therapeutics (NASDAQ:KRTX) PT Lowered to $235.00 at Royal Bank of Canada

Karuna Therapeutics (NASDAQ:KRTX – Free Report) had its price objective decreased by Royal Bank of Canada from $249.00 to $235.00 in a research note published on Friday, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. Several other equities analysts have also recently weighed in on the stock. Morgan Stanley […] ....

United States , Peter Jeffrey Conn , Jeffreym Jonas , Eric Elenko , Lauriej Olson , Andrew Miller , Ballentine Partners , Calamos Advisors , Fiera Capital Corp , Karuna Therapeutics Inc , Royal Bank , Securities Exchange Commission , Morgan Stanley , Jpmorgan Chase Co , Financial Services Group Inc , China Universal Asset Management Co , Karuna Therapeutics , Free Report , Moderate Buy , Get Free Report , Director Laurie , Director Jeffrey , Exchange Commission , Services Group , Universal Asset Management , Capital Corp ,

Royal Bank of Canada Cuts Karuna Therapeutics (NASDAQ:KRTX) Price Target to $235.00

Karuna Therapeutics (NASDAQ:KRTX – Free Report) had its target price cut by Royal Bank of Canada from $249.00 to $235.00 in a research report report published on Friday morning, Benzinga reports. They currently have an outperform rating on the stock. KRTX has been the subject of a number of other research reports. HC Wainwright reaffirmed […] ....

New Zealand General , New Zealand , United States , Troya Ignelzi , Peter Jeffrey Conn , Andrew Miller , Lauriej Olson , Eric Elenko , Vanguard Group Inc , Morgan Stanley , Karuna Therapeutics Company Profile , Securities Exchange Commission , Karuna Therapeutics Inc , Wellington Management Group , Jpmorgan Chase Co , Norges Bank , Royal Bank , Karuna Therapeutics , Free Report , Moderate Buy , Therapeutics Trading Down , Get Free Report , Exchange Commission , Director Laurie , Management Group , Karuna Therapeutics Daily ,

FY2025 EPS Estimates for Karuna Therapeutics, Inc. (NASDAQ:KRTX) Lowered by Analyst

Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) – Investment analysts at Zacks Research lowered their FY2025 EPS estimates for Karuna Therapeutics in a research note issued on Thursday, June 15th. Zacks Research analyst S. Ganoria now forecasts that the company will earn ($5.07) per share for the year, down from their previous forecast of ($4.81). […] ....

New York , United States , Peter Jeffrey Conn , Andrew Miller , Andrew Craig Miller , Lauriej Olson , Eric Elenko , Capital Impact Advisors , York State Common Retirement Fund , Cantor Fitzgerald , International Biotechnology Trust , Zacks Research , Karuna Therapeutics Inc , Wells Fargo Company , Prelude Capital Management , Ameriprise Financial Inc , Securities Exchange Commission , Karuna Therapeutics , Get Rating , Karuna Therapeutic , Therapeutics Trading Down , Capital Management , Impact Advisors , Craig Miller , Exchange Commission , Director Laurie ,